Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 45,581 | 33,469 | 28,843 | 46,240 | 39,786 |
| Operating Income | -45,581 | -33,469 | -28,843 | -46,240 | -39,786 |
| Interest Expense | 1,615 | 1,464 | 1,443 | 1,086 | 1,401 |
| Other Income | 271 | -308 | -118 | -3,982 | -34 |
| Pre-tax Income | -46,925 | -35,241 | -30,404 | -51,308 | -41,221 |
| Income Tax | -128 | -85 | 90 | -48 | 38 |
| Net Income Continuous | -46,797 | -35,156 | -30,494 | -51,260 | -41,259 |
| Net Income | $-46,797 | $-35,156 | $-30,494 | $-51,260 | $-41,259 |
| EPS Basic Total Ops | -1.46 | -1.12 | -0.99 | -1.67 | -1.36 |
| EPS Basic Continuous Ops | -1.46 | -1.13 | -0.99 | -1.68 | -1.36 |
| EPS Diluted Total Ops | -1.46 | -1.12 | -0.99 | -1.67 | -1.36 |
| EPS Diluted Continuous Ops | -1.46 | -1.13 | -0.99 | -1.68 | -1.36 |
| EPS Diluted Before Non-Recurring Items | -1.46 | -1.12 | -0.99 | -1.57 | -1.36 |
| EBITDA(a) | $-45,475 | $-33,380 | $-28,766 | $-46,172 | $-39,721 |